Tissue Predictors of Abiraterone Benefit

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

May 1, 2023

Study Completion Date

November 1, 2023

Conditions
Metastatic Castration-resistant Prostate Cancer
Trial Locations (1)

300211

Tianjin Medical Unversity Second Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

Beijing Chao Yang Hospital

OTHER

collaborator

The Second Hospital of Hebei Medical University

OTHER

collaborator

Affiliated Hospital of Hebei University

OTHER

lead

Tianjin Medical University Second Hospital

OTHER

NCT03176381 - Tissue Predictors of Abiraterone Benefit | Biotech Hunter | Biotech Hunter